Updated Saturday, December 16, 2017
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Subscription
Advertising
Thanking Peer Reviewers
 Language Polishing
Journal of Integrative Medicine: Volume 15, 2017   Issue 5,  Pages: 373–378

DOI: 10.1016/S2095-4964(17)60358-3
Research Article
Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial
1. Maryam Sharifi-Ardani (School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin 341197-5981, Iran )
2. Leili Yekefallah (School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin 341197-5981, Iran )
3. Saeed Asefzadeh (Social Determinants of Health Research Center, Qazvin University of Medical Sciences, Qazvin 341197-5981, Iran )
4. Marjan Nassiri-Asl (Cellular and Molecular Research Center, Department of Pharmacology, Qazvin University of Medical Sciences, Qazvin 341197-5981, Iran )
ABSTRACT BACKGROUND: Amiodarone is a useful antiarrhythmic drug. Phlebitis, caused by intravenous amiodarone, is common in patients in coronary care units (CCUs). OBJECTIVE: The aim of this study was to evaluate the effect of topical chamomile on the incidence of phlebitis due to the administration of an amiodarone infusion into the peripheral vein. DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: This was a randomized, double-blind clinical trial, conducted on 40 patients (n = 20 per group) in two groups—an intervention group (chamomile ointment) and a control group (lanoline, as a placebo), hospitalized in the CCUs and undergoing an amiodarone infusion into the peripheral vein over 24 h. Following the cannulation and commencement of the infusion, placebo or chamomile ointment was rubbed in, up to 10 cm superior to the catheter and repeated every eight hours for three days. The cannula site was then assessed based on the phlebitis checklist. MAIN OUTCOME MEASURES: The incidence and time of occurrence of phlebitis, relative risk, severity of phlebitis were the main outcome measures. RESULTS: Nineteen patients (19/20) in the control group had phlebitis on the first day of the study and one patient (20/20) on the second day. In the intervention group, phlebitis occurred in 13 cases (13/20) on the first day and another two (2/7) was found on the second day. The incidence of phlebitis was significantly different between two groups (P = 0.023). The cumulative incidence of phlebitis in the intervention group (15/20) is significantly later and lower than that in the control group (20/20) during two days (P = 0.008). Two patients in the intervention group did not develop phlebitis at all during the 3-day study. Also, the relative risk of phlebitis in the two groups was 0.68 (P = 0.008 5). A significant difference was not observed with regard to phlebitis severity in both groups. CONCLUSION: It seems that phlebitis occurred to a lesser extent and at a later time frame in the intervention group compared to control group. Topical chamomile may be effective in decreasing the incidence of phlebitis due to an amiodarone infusion.TRIAL REGISTRATION: This protocol was registered in the Iranian Registry of Clinical Trials (IRCT2014042017361N1). Keywords: phlebitis; amiodarone; prevention; chamomile; clinical trial; plants, medicinal
Welcome to JIM! You are the number 386 reader of this article!
Download Article:
[Full Text]      [PDF]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Sharifi-Ardani M, Yekehfallah L, Asefzadeh S, Nassiri-Asl M. Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial. J Integr Med. 2017; 15(5): 373–378.
References:
1Trappe HJ. Concept of the five ‘A’s for treating emergency arrhythmias[J].J Emerg Trauma Shock, 2010, 3(2): 129–136.  
2Iqbal FM, Chawla B, Koneru J, Bikkina M. Amiodarone-induced thrombosis: a case series and brief review of the literature[J].Am J Ther, 2012, 19(5): 389–391.  
3Eppert HD, Goddard KB. Administration of amiodarone during resuscitation of ventricular arrhythmias[J].J Emerg Nurs, 2010, 36(1): 26–28.  
4Norton L, Ottoboni LK, Varady A, Yang-Lu CY, Becker N, Cotter T, Pummer E, Haynes A, Forsey L, Matsuda K, Wang P. Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications[J].Am J Crit Care, 2013, 22(6): 498–505.  
5Saini R, Agnihotri M, Gupta A, Walia I. Epidemiology of infiltration and phlebitis[J].Nurs Mid Res J, 2011, 7(1): 22–33.  
6Boyce BA, Yee BH. Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone[J].Crit Care Nurse, 2012, 32(4): 27–34.  
7Mowry JL, Hartman LS. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin[J].West J Nurs Res, 2011, 33(3): 457–471.  
8Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): an overview[J].Pharmacogn Rev, 2011, 5(9): 82–95.  
9Amin GH, Shirzad M. Babonneh[J].J Islamic Iran Tradit Med, 2011, 1(4): 391–396.  
10Jabri MA, Sakly M, Marzouki L, Sebai H. Chamomile (Matricaria recutita L.) decoction extract inhibits in vitro intestinal glucose absorption and attenuates high fat diet-induced lipotoxicity and oxidative stress[J].Biomed Pharmacother, 2017, 87: 153–159.  
11Jabri MA, Aissani N, Tounsi H, Sakly M, Marzouki L, Sebai H. Protective effect of chamomile (Matricaria recutita L.) decoction extract against alcohol-induced injury in rat gastric mucosa[J].Pathophysiology, 2017, 24(1): 1–8.  
12Sebai H, Jabri MA, Souli A, Hosni K, Rtibi K, Tebourbi O, El-Benna J, Sakly M. Chemical composition, antioxidant properties and hepatoprotective effects of chamomile (Matricaria recutita L.) decoction extract against alcohol-induced oxidative stress in rat[J].Gen Physiol Biophys, 2015, 34(3): 263–275.  
13Kazemian H, Ghafourian S, Sadeghifard N, Badakhsh B, Heidari H, Taji A, Shavalipour A, Mohebi R, Ebrahim-Saraie HS, Houri H, Houshmandfar R. In vivo antibacterial and wound healing activities of Roman chamomile (Chamaemelum nobile). Infect Disord Drug Targets. 2016; Epub ahead of print.
14Srivastava JK, Shankar E, Gupta S. Chamomile: a herbal medicine of the past with bright future[J].Mol Med Rep, 2010, 3(6): 895–901.  
15Reis PE, Carvalho EC, Bueno PC, Bastos JK. Clinical application of Chamomilla recutita in phlebitis: dose response curve study[J].Rev Lat Am Enfermagem, 2011, 19(1): 3–10.  
16Aradmehr M, Azhari S, Ahmadi S, Azmoude E. The effect of chamomile cream on episiotomy pain in primiparous women: a randomized clinical trial[J].J Caring Sci, 2017, 6(1): 19–28.  
17Alexander M. Infusion nursing standards of practice[J].J Infus Nurs, 2011, 34(Suppl 1): S65.  
18Gallant P, Schultz AA. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters[J].J Infus Nurs, 2006, 29(6): 338–345.  
19Hashempur MH, Lari ZN, Ghoreishi PS, Daneshfard B, Ghasemi MS, Homayouni K, Zargaran A. A pilot randomized double-blind placebo-controlled trial on topical chamomile (Matricaria chamomilla L.) oil for severe carpal tunnel syndrome[J].Complement Ther Clin Pract, 2015, 21(4): 223–228.  
20Shoara R, Hashempur MH, Ashraf A, Salehi A, Dehshahri S, Habibagahi Z. Efficacy and safety of topical Matricaria chamomilla L. (chamomile) oil for knee osteoarthritis: a randomized controlled clinical trial[J].Complement Ther Clin Pract, 2015, 21(3): 181–187.  
21Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity[J].Life Sci, 2009, 85(19–20): 663–669.  
22Nekuzad N, Ashke Torab T, Mojab F, Alavi-Majd H, Azadeh P, Ehtejab G. Effect of external use of sesame oil in the prevention of chemotherapy-induced phlebitis[J].Iran J Pharm Res, 2012, 11(4): 1065–1071.  
23Bagheri-Nesami M, Shorofi SA, Hashemi-Karoie SZ, Khalilian A. The effects of sesame oil on the prevention of amiodarone-induced phlebitis[J].Iran J Nurs Midwifery Res, 2015, 20(3): 365–370.  
24Martinho RDFS, Rodrigues AB. Occurrence of phlebitis in patients on intravenous amiodarone[J].Einstein, 2008, 6(4): 459–462.  
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号